발간보고서
home > 자료실> 발간보고서
- 글자크기
Saudi Arabia Pharmaceutical Industry
| 작성자 | 관리자 | 카테고리 | 전문가 인사이트 |
|---|---|---|---|
| 작성일 | 2018-11-26 | 조회수 | 5,368 |
| 원문 | 보건복지부 | ||
| 출처 | |||
Saudi Arabia Pharmaceutical Industry
Introduction
The pharmaceutical industry in the Gulf Cooperative Countries (GCC) started some 30 years ago & the main idea was to decrease the cost of medication which has increased sharply at that time, some of the GCC countries started manufacturing pharmaceuticals under license from major international pharma companies in the world & the purpose was to get quality products & also to develop Know-How of such an industry as well as the potential of technology transfer
Soon after they discover the generic business manufacturing of medicine & the purchase of API much cheaper than from the major Pharma companies which they manufacture with them, they kicked off their partners & direct their manufacturing to the generic products & now the majority of pharma manufacturing facilities are generic ones mainly at KSA & UAE
The pharmaceutical markets in the GCC Countries has witnessed considerable progress over the years due to favorable demographic & economic factors, and strong government support for healthcare developments, which has now passed the emerging phase to expansion phase, where a lot of projects for a pharma manufacturing facilities are going on for developments specially in KSA & UAE
Although Pharmaceutical industry started long time ago, but still there, they are importing 75% of their medicines from international companies & that explain the potential for growth for pharmaceutical industry in the GCC Countries & the need of new additional manufacturing facilities especially in biopharmaceutical & Biotechnology products, where biotechnology should be considered as a national security for the countries & the governments in the GCC Countries started to give utmost priority & much needed support to secure this industry with the full understanding of high investment cost for such an important industry, now a days the GCC Countries are seriously considering the development of biotechnology industry and facilitated foreign investment agreements with international companies like SaudiVax which is a new company manufacturing Vaccines & Biopharmaceuticals for KSA & GCC Countries, they are partner with PnuVAX an international known Canadian Vaccine & therapeutic antibody company also Almas International Pharmaceutical Industry, which will establish the largest vaccines production plant at KAEC for BCG vaccine as the start of their production & then they plan to produce Polio vaccine & Tuberculin vaccines later on, this will happen with an alliance with EU Pharma Company called AJ Vaccines which is from Denmark
Another example from UAE where Merk-Serono the Biopharmaceutical division of Merck entered into a local manufacturing agreement with Abu-Dhabi -based NeoPharma Company to manufacture locally in UAE the following two products 1) EUTHYROX which is a hormone therapy 2) GLUCOPHAGE a standard oral treatment for type 2 diabetes for catering the regional demand of such a medicines & also will help UAE to turn into a pharmaceutical export base.
Saudi Arabia Pharma Manufacturing facilities 2018:
Number of Generic facilities are 20/ API are 2/Biopharma are 2 + 2 (8&9) will be ready by 2023
Upcoming Pharma Manufacturing facilities will be ready by 2023
Total number of Manufacturing facilities will be 34 as reported by 2018 / (Ref. BMI Pharma & Healthcare report 2017 KSA)
|
No. |
Upcoming Pharma Facility in KAEC |
Generic Manufacturing facility |
API Manufacturing Facility |
Bio Pharma Manufacturing Facility |
|
1 |
Shamla Pharma Industry (KSA) |
Batterjee |
RAHMA |
ARABIO Co. |
|
2 |
JULPHAR (UAE) |
Jamjoom |
CAD ME Pharmaceutical Industry |
SEDAIR Pharma |
|
3 |
Pfizer (American) |
PSI |
|
|
|
4 |
SANOFI (French) |
SAJA (Saudi-Japanese Pharma) |
|
|
|
5 |
Pharmaline (Lebanon) |
DALLAH Pharma |
|
|
|
6 |
Aurabindo (India) |
Tabuk (2 Facilities) |
|
|
|
7 |
RamPharma (India) |
AJA Pharma (Injectable) |
|
|
|
8 |
SaudiVAX with Canadian Co. (PnuVAX) Biopharma |
SPEMACO |
|
|
|
9 |
Almas International Pharmaceutical Industry with EU (AJ Vaccine) Biopharma |
Deef Pharma |
|
|
|
10 |
|
Watan Pharma |
|
|
|
11 |
|
ammam Pharma |
|
|
|
12 |
|
Riyadh Pharma |
|
|
|
13 |
|
Saudi Pharmaceuticals |
|
|
|
14 |
|
MS Pharma (Jordan) |
|
|
|
15 |
|
JPI |
|
|
|
16 |
|
ADAMCO |
|
|
|
17 |
|
Baxter Saudi Co. (IV & PD solutions) |
|
|
|
18 |
|
MECP |
|
|
|
19 |
|
AL Jazeera Pharma |
|
|
|
20 |
|
Glaxo Saudi Pharma |
|
|
From previous table, we can identify the priority sectors for investment at the Pharma market of Saudi Arabia, where biologics & biopharma are top priority also injectable & API manufacturing facilities
1. Plasma Production
2. Vaccines Production
3. Biologics/Biosimilers
4. Sterile Injectable
5. APIs
6. Soft Gelatin Capsules (SGC)
7. IV & Dialysis Solutions
8. Solid Oral dosage Forms
The Government of Saudi Arabia has implemented the NATIONAL TRANSFORMATION PROGRAM (NTP) 2020 to open the door for the vision 2030 to be achieved
Objectives:
o Government Harmony: for government agencies to work together for one target or objective
o National Security: to insure self-sufficiency & sustainability of medicines
o Technology Transfer: to strengthen & add value to pharma industry in the country
o Quality Jobs & Training: this business will create both jobs & training opportunities
o Increase Local Manufacturing : from 20% to 40% by promoting local manufacturing environments & hence will increase Foreign Direct Investment (FDI) flow to the Kingdom like KAEC (King Abdullah Economic City)
o Improve & speedup the registration process by improving the system at SFDA: that has been achieved now by implementing the new Saudi Drug Registration System as an electronic one (SDR), where everything now is being done through the SDR system from submission of eCTD to follow you on the development electronically to answering any question or query directly to them without the need to arrange for an appointment or meetings till you can print registration certificate of your product from your office
Kingdom of Saudi Arabia (KSA) represent a good opportunity for investments where their ranking is 38 out of 128 countries in the world & 3 steps behind South Korea (35th),17positionaheadofChina(55th)&26positionaheadofBrazil(64th)
(Source: the international property right index (IPRI) 2016)
Opportunity & support by Saudi Industrial Development FUND (SIDF)
It is a Government soft loans ( www.sidf.gov.sa ) to support & encourage local industry in the kingdom especially strategic industries Like Vaccines …etc.
The pharmaceutical industry in Kingdome of Saudi Arabia is now passing the start point & is in the expansion stage & it is changing through reform & simplifying government regulations, increasing its efficiency & expanding the infrastructure of healthcare, based on that the industry in KSA & UAE will face many changes in the next few years (2025), which will provide importunate investment opportunities. The local production is expected to increase & the opportunity is in biotechnology & biopharmaceuticals startup there & expansion later on
In general Saudi Arabia & UAE represent in value of GCC Pharma Market more than 80%, which makes it very strong & attractive market for investment in the industrial pharmacy segment within the Middle East countries
Globally also, over 208 Billion US$ of patent protected pharmaceuticals will be replaced by generics between 2010 to 2017; during that 7 years & out of that years, 77 billion US$ of patented drugs are expired for cardiovascular drugs alone.
This will create an opportunity for generic drugs manufacturers, including in the GCC & MENA, to expand sales and manufacturing, if supported by health plans, regulatory simplifications & trade incentives.
For any explanation or questions, please contact: kehatip@khidi.or.kr or 010 3403 0032
Mr. Kemal Hatip – Executive Consultant/Korea Health Industry Development Institute (KHIDI)
Department of Pharmaceutical & Bio –Pharmaceutical Industry
Pharma & Bio-Pharma Global Team
- 이전글 이전글이 없습니다.
- 다음글 다음글이 없습니다.
